0001225208-21-002223.txt : 20210211
0001225208-21-002223.hdr.sgml : 20210211
20210211173358
ACCESSION NUMBER: 0001225208-21-002223
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210209
FILED AS OF DATE: 20210211
DATE AS OF CHANGE: 20210211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McClellan Mark B.
CENTRAL INDEX KEY: 0001567006
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 21621187
MAIL ADDRESS:
STREET 1: THE BROOKINGS INSITUTION
STREET 2: 1775 MASSACHUSETTS AVE., NW
CITY: WASHINGTON
STATE: DC
ZIP: 20036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0103
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0306
4
2021-02-09
0000200406
JOHNSON & JOHNSON
JNJ
0001567006
McClellan Mark B.
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
Deferred Share Units
2021-02-09
4
A
0
1123.0000
0.0000
A
Common Stock
1123.0000
12818.3790
D
Grant of Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
mcclellanpoa.txt
Raavi K. Deol, as attorney-in-fact for Mark B. McClellan
2021-02-11
EX-24
2
mcclellanpoa.txt
POWER OF ATTORNEY
Directors
Know all persons by these presents, that the undersigned hereby constitutes and
appoints each of Matthew Orlando, Renee Brutus, Pinto Adhola, Michelle R. Ryan,
Raavi Deol and Elizabeth Carew, signing singly, as the undersigned's true and
lawful attorneys-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as a Director of Johnson & Johnson (the "Company"), Forms 3, 4 and 5 in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended, and the rules thereunder (the "Exchange Act") and Form 144 in
accordance with Rule 144 of the Securities Act of 1933, as amended (the
"Securities Act");
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, 5 and
144 and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act or Rule 144 of the Securities Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file reports pursuant to Section 16 of the
Exchange Act with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date set forth below.
/s/ Mark B. McClellan
Name: Mark B. McClellan
Date: February 11, 2021